RXO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.47 USD | -1.21% |
|
+7.74% | -11.99% |
| May. 02 | RXO Swings to Q1 Loss as Revenue Falls; Shares Rise | MT |
| May. 02 | Transcript : RXO, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 2,000 | 2,721 | 2,436 | - | - |
| Enterprise Value (EV) 1 | 2,357 | 3,075 | 2,761 | 2,717 | 2,742 |
| P/E ratio | 21.8 x | 775 x | -303 x | 38.4 x | 21.5 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 0.42 x | 0.69 x | 0.62 x | 0.56 x | 0.53 x |
| EV / Revenue | 0.49 x | 0.78 x | 0.71 x | 0.62 x | 0.6 x |
| EV / EBITDA | 7.7 x | 23.3 x | 23.6 x | 14.2 x | 12.2 x |
| EV / FCF | 9.28 x | 123 x | 76.4 x | 27.4 x | - |
| FCF Yield | 10.8% | 0.81% | 1.31% | 3.65% | - |
| Price to Book | 3.38 x | 4.58 x | 3.79 x | 3.44 x | 3.14 x |
| Nbr of stocks (in thousands) | 116,303 | 117,001 | 117,548 | - | - |
| Reference price 2 | 17.20 | 23.26 | 20.47 | 20.47 | 20.47 |
| Announcement Date | 2/7/23 | 2/8/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 4,796 | 3,927 | 3,899 | 4,348 | 4,562 |
| EBITDA 1 | - | 306 | 132 | 116.9 | 191.5 | 225.1 |
| EBIT 1 | - | 220 | 65 | 56.25 | 129.5 | 176.9 |
| Operating Margin | - | 4.59% | 1.66% | 1.44% | 2.98% | 3.88% |
| Earnings before Tax (EBT) 1 | 191 | 119 | 4 | -5.558 | 82.96 | 95.55 |
| Net income 1 | 150 | 92 | 4 | -6.344 | 62.67 | 90.19 |
| Net margin | - | 1.92% | 0.1% | -0.16% | 1.44% | 1.98% |
| EPS 2 | - | 0.7900 | 0.0300 | -0.0676 | 0.5337 | 0.9509 |
| Free Cash Flow 1 | - | 254 | 25 | 36.12 | 99.16 | - |
| FCF margin | - | 5.3% | 0.64% | 0.93% | 2.28% | - |
| FCF Conversion (EBITDA) | - | 83.01% | 18.94% | 30.9% | 51.77% | - |
| FCF Conversion (Net income) | - | 276.09% | 625% | - | 158.21% | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 9/28/22 | 2/7/23 | 2/8/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,120 | 1,010 | 963 | 976 | 978 | 913 | 925.3 | 993.6 | 1,053 | 1,003 | 1,072 |
| EBITDA 1 | - | 64 | 37 | 38 | 26 | 31 | 15 | 26.01 | 31.15 | 42.03 | 32.89 | 44.5 |
| EBIT 1 | - | 43 | 19 | 20 | 10 | 16 | -1 | 11.96 | 16.28 | 26.59 | 17.89 | 29 |
| Operating Margin | - | 3.84% | 1.88% | 2.08% | 1.02% | 1.64% | -0.11% | 1.29% | 1.64% | 2.53% | 1.78% | 2.71% |
| Earnings before Tax (EBT) 1 | - | -6 | -3 | 6 | -3 | 4 | -21 | -0.7 | 4.467 | 15.43 | 7.5 | 18 |
| Net income 1 | 13 | -4 | - | 3 | -1 | 2 | -15 | -1.482 | 1.705 | 9.629 | 6 | 13 |
| Net margin | - | -0.36% | - | 0.31% | -0.1% | 0.2% | -1.64% | -0.16% | 0.17% | 0.91% | 0.6% | 1.21% |
| EPS 2 | 0.1100 | -0.0300 | - | 0.0300 | -0.0100 | 0.0200 | -0.1300 | -0.0209 | 0.008920 | 0.0824 | 0.0500 | 0.1100 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/30/22 | 2/7/23 | 5/3/23 | 8/2/23 | 11/7/23 | 2/8/24 | 5/2/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 357 | 354 | 326 | 282 | 306 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 1.167 x | 2.682 x | 2.784 x | 1.472 x | 1.36 x |
| Free Cash Flow 1 | - | 254 | 25 | 36.1 | 99.2 | - |
| ROE (net income / shareholders' equity) | - | 21.8% | 6.1% | 2.98% | 12% | 14.7% |
| ROA (Net income/ Total Assets) | - | 8.82% | 1.87% | 1.21% | 3.77% | - |
| Assets 1 | - | 1,044 | 214.2 | -522.8 | 1,664 | - |
| Book Value Per Share 2 | - | 5.090 | 5.080 | 5.400 | 5.950 | 6.520 |
| Cash Flow per Share 2 | - | 2.680 | 0.7500 | 1.260 | 3.300 | - |
| Capex 1 | - | 57 | 64 | 45.2 | 49.3 | 52.3 |
| Capex / Sales | - | 1.19% | 1.63% | 1.16% | 1.13% | 1.15% |
| Announcement Date | 9/28/22 | 2/7/23 | 2/8/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
20.47
USD
Average target price
20
USD
Spread / Average Target
-2.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.99% | 2.44B | |
| -10.34% | 40.22B | |
| -16.02% | 17.35B | |
| +2.57% | 11.39B | |
| -5.68% | 10.78B | |
| -13.00% | 2.32B | |
| +9.11% | 1.67B | |
| -16.02% | 1.43B | |
| -0.91% | 1.23B | |
| +71.88% | 1.21B |
- Stock Market
- Equities
- RXO Stock
- Financials RXO, Inc.